Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06981286

Oral Health Parameter-Based Diabetes Type 2 Indication Using Machine Learning

Oral Health Parameter-Based Diabetes Type 2 Indication Using Machine Learning in Older Individuals With Mild Cognitive Impairment

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Blekinge Institute of Technology · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This study aims to explore the potential of using machine learning (ML) algorithms to predict Diabetes type2, based on oral health and demographic data. The objective is to evaluate the effectiveness of various ML models and identify the most relevant oral health indicators for predicting type 2 diabetes in individuals with mild cognitive impairment aged 60 and above.

Detailed description

This cross-sectional study utilizes oral health and demographic data from the Swedish National Study on Aging and Care (SNAC-B). Participants aged 60 years or older with Mild Cognitive Impairment will be included in the analysis. The data will be used to develop and evaluate machine learning models for predicting type 2 diabetes. Objectives: 1. Primary Objective: To assess the potential of oral health parameters for binary classification of type 2 diabetes or not. 2. Secondary Objective: To identify the most influential oral health parameters contributing to type 2 diabetes predictions. 3. Tertiary Objective: To compare the performance of Random Forest (RF), Support Vector Machine (SVM), and CatBoost (CB) classifiers in predicting type 2 diabetes using oral health data.

Conditions

Interventions

TypeNameDescription
OTHERA dataset comprising participants withT2D will be used to evaluate the classification performance of various machine learning techniques.A dataset comprising participants with T2D will be used to evaluate the classification performance of various machine-learning techniques.

Timeline

Start date
2025-08-30
Primary completion
2026-12-01
Completion
2027-07-01
First posted
2025-05-20
Last updated
2025-05-20

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06981286. Inclusion in this directory is not an endorsement.